CNR1 and pancreatic insulinoma: Conversely, pharmacological abrogation of CB1R with either a global (AM251) or peripherally restricted (JD-5037) CB1R antagonist was reported to rescue such effects by releasing the ACEA/cannabinoid blockade of Ex-4 action in both mouse insulinoma cells and human islets (25).